Application | Comment | Organism |
---|---|---|
medicine | use of mutant E201Q/N243D in Antibody Dependent Enzyme Prodrug Therapy ADEPT by fusion to the human anti-HER2/neu single chain Fv. In vitro the construct binds specifically to HER2/neu expressing tumor cells and localizes the enzyme to tumor cells, where the enzymatic activity of the mutant, but not the wild type enzyme, results in phosphorolysis of the prodrug, 2-fluoro-2'-deoxyadenosine to the cytotoxic drug 2-fluoroadenine causing inhibition of tumor cell proliferation | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
E201Q/N243D | unlike wild-type, mutant is able to cleave prodrugs 2-fluoro-2'-deoxyadenosine, Cladribine, and 2-fluoroadenosine | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.059 | - |
guanosine | mutant E201Q/N243D | Homo sapiens | |
0.264 | - |
2-fluoro-2'-deoxyadenosine | mutant E201Q/N243D | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
2-fluoro-2-deoxyadenosine + phosphate | no substrate for wild-type, substrate of double mutant E201Q/N243D | Homo sapiens | adenine + 2-fluoro-2-deoxy-alpha-D-ribose 1-phosphate | - |
? | |
guanosine + phosphate | - |
Homo sapiens | guanine + alpha-D-ribose 1-phosphate | - |
? |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.155 | - |
2-fluoro-2'-deoxyadenosine | mutant E201Q/N243D | Homo sapiens | |
60 | - |
guanosine | mutant E201Q/N243D | Homo sapiens |
kcat/KM Value [1/mMs-1] | kcat/KM Value Maximum [1/mMs-1] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
568 | - |
2-fluoro-2'-deoxyadenosine | mutant E201Q/N243D | Homo sapiens | |
1020 | - |
guanosine | mutant E201Q/N243D | Homo sapiens |